Abstract
This study aimed to evaluate the clinical outcome of recurrent early-stage high-risk epithelial ovarian cancer patients. Demographic and clinicopathological data were collected from women enrolled in GOG 157 who underwent surgical staging and had recurrent disease. Survival probability was estimated using Kaplan-Meier method, and hazard ratio of death was analyzed using Cox regression model. Of 74 women with recurrent early-stage high-risk ovarian cancer, the median age at recurrence was 63 years; 93% were White, 2.7% were Black, 2.7% were Asian, and 1.4% were Others. Fifty-eight percent had stage I, and the remainder had stage II disease. Clear cell, serous, endometrioid, mucinous, and other tumors consisted of 28.4%, 25.7%, 24.3%, 16.2%, and 5.4% of patients, respectively; in addition, 36.5% had ascites, 33.8% had positive cytology, and 43.2% had ruptured tumors. Fifty-eight percent underwent three cycles, and 42% had six cycles of adjuvant chemotherapy with paclitaxel and carboplatin. Recurrence was diagnosed clinically in 46% and radiographically in 54% of women. The median time from completion of primary chemotherapy to recurrence (treatment-free interval, TFI) was 21 months. Overall, median survival after recurrence was 2...Continue Reading
References
Sep 1, 1992·Journal of Clinical Epidemiology·C La VecchiaM Fasoli
Jun 1, 1992·British Journal of Obstetrics and Gynaecology·K S Raju, C D Wolfe
May 15, 1990·Cancer·P SeveldaH Salzer
Feb 1, 1990·Gynecologic Oncology·M E GoreT Dawson
Jul 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. BertelsenP. Ladehoff
Sep 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. SjövallN. Einhorn
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Desiree F KolomainenMartin E Gore
Dec 14, 2004·The New England Journal of Medicine·Peter G RoseUNKNOWN Gynecologic Oncology Group
Jul 25, 2006·Gynecologic Oncology·Jeffrey BellUNKNOWN Gynecologic Oncology Group
Citations
Feb 15, 2012·Pharmacogenomics·Li YanSun Hai-Yan
Jul 28, 2013·International Journal of Clinical Oncology·Yui TomitaKumi Shimamoto
Sep 13, 2012·BMC Cancer·Ingiridur SkirnisdottirAnders Isaksson
Nov 7, 2013·BMC Cancer·Ingiridur SkirnisdottirTomas Seidal
Jul 3, 2015·Oncology Letters·Jin Zhang, Hongxia Li
Feb 24, 2015·Gynecologic Oncology·Helen E DinkelspielJason D Wright
Nov 3, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Terence C ChuaDavid L Morris
Mar 24, 2016·Virchows Archiv : an International Journal of Pathology·Volker EndrisPeter Schirmacher
May 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E CaluraC Romualdi
May 10, 2016·Obstetrics and Gynecology·Sudeshna ChatterjeeJason D Wright
Dec 1, 2017·Journal of Gynecologic Oncology·Chien An ChenWen Fang Cheng
Jun 3, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ingiridur SkirnisdottirHelena Åkerud
Feb 2, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angiolo GadducciEnrico Sartori
Jan 12, 2019·Obstetrics and Gynecology·Peter G RoseLarry J Copeland
Jan 31, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Antonino DittoFrancesco Raspagliesi
Sep 30, 2017·Journal of Korean Medical Science·Zhen TanChuanGang Fu
Jun 5, 2019·Journal of Cellular Biochemistry·Lei WangShanshan Zhao
Feb 22, 2012·Clinical Obstetrics and Gynecology·Leigh G SeamonLarry J Copeland
Jun 2, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Derya Kilic SakaryaDemir Ozbasar
Aug 11, 2017·Acta Obstetricia Et Gynecologica Scandinavica·Ingvild VistadAnne Dørum
Oct 1, 2020·BMC Cancer·Jun HuYumei Wu
Nov 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paolo MartiniChiara Romualdi
Oct 31, 2020·Cancer Immunology, Immunotherapy : CII·Tao DaoDavid A Scheinberg
Mar 8, 2021·International Journal of Clinical Oncology·Shinichi TateMakio Shozu
Aug 26, 2020·Pathology, Research and Practice·Akiko YamamotoMasanobu Kitagawa
Jan 7, 2022·Obstetrics and Gynecology·John K ChanJeffrey G Bell